000			02723nam a2200217Ia 4500
999			_c40274 _d40274
003			OSt
005			20210217154017.0
008			160316s2010 xxu||||| |||| 00| 0 eng d
020			_a9780521116565
040			_cn
082			_a362.170000 _bPOG
100			_aPogge Thomas
245			_aIncentives for global public health
260			_aCambridge _bCambridge University Press _c2010
300			_a512p _cxix
365			_b Rs. 3,100
505			_aContents: Introduction: access to essential medicines: public health and international law Thomas Pogge, Matthew Rimmer and Kim Rubenstein; Part I. International Trade: 1. TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis Rochelle Cooper Dreyfuss; 2. The TRIPS waiver as a recognition of public health concerns in the WTO Andrew Mitchell and Tania Voon; 3. Public law challenges to the regulation of pharmaceutical patents in the US Bilateral Free Trade Agreements Hitoshi Nasu; 4. Global health and development: patents and public interest Elizabeth Siew Kuan Ng; Part II. Innovation: 5. The Health Impact Fund: boosting innovation without obstructing free access Thomas Pogge; 6. The Health Impact Fund: a critique Kathleen Liddell; 7. A prize system as a partial solution to the health crisis in the developing world William W. Fisher and Talha Syed; 8. Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation Thomas Faunce; Part III. Intellectual Property: 9. Opening the dam: patent pools, innovation, and access to essential medicines Dianne Nicol and Jane Nielsen; 10. Open source drug discovery: a revolutionary paradigm or a utopian model? Krishna Ravi Srinivas; 11. Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? Charles Lawson and Barbara Hocking; 12. The Lazarus effect: the (RED) campaign and creative capitalism Matthew Rimmer; Part IV. Health-Care: 13. Beyond TRIPS: the role of non-state actors and access to essential medicines Noah Benjamin Novogrodsky; 14. Securing health through rights Katharine Young; 15. The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India Rajshree Chandra; 16. Tipping point: Thai compulsory licenses redefine essential medicines debate Jonathan Burton-MacLeod
650			_a1. Drug - Organization & Administration - Legislation2. Drugs - Essential - Supply & Distribution3. Health Service Accessibility
700			_aRimer Mathew _aRubenstein Kim
942			_2ddc _cBK